Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-15

Clinical Trial Update: Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating rupatadine for efficacy and safety in cold contact urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rupatadine (rupatadine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Cold Contact Urticaria | Phase 2 | Status: COMPLETED